Methylglyoxal is associated with changes in kidney function among individuals with screen-detected Type 2 diabetes mellitus
Aims The glycolysis-derived metabolite methylglyoxal has been linked to clinical microvascular complications, including diabetic nephropathy. We aimed to further investigate the hypothesis that methylglyoxal is involved in decline in renal function by assessing the associations between measures of r...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
[2016]
|
| In: |
Diabetic medicine
Year: 2016, Jahrgang: 33, Heft: 12, Pages: 1625-1631 |
| ISSN: | 1464-5491 |
| DOI: | 10.1111/dme.13201 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1111/dme.13201 Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/dme.13201 
|
| Verfasserangaben: | T.M. Jensen, D. Vistisen, T. Fleming, P.P. Nawroth, P. Rossing, M.E. Jørgensen, T. Lauritzen, A. Sandbæk and D.R. Witte |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1697276180 | ||
| 003 | DE-627 | ||
| 005 | 20230428022036.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200506s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/dme.13201 |2 doi | |
| 035 | |a (DE-627)1697276180 | ||
| 035 | |a (DE-599)KXP1697276180 | ||
| 035 | |a (OCoLC)1341318594 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Jensen, Troels Mygind |e VerfasserIn |0 (DE-588)1209606658 |0 (DE-627)1697277322 |4 aut | |
| 245 | 1 | 0 | |a Methylglyoxal is associated with changes in kidney function among individuals with screen-detected Type 2 diabetes mellitus |c T.M. Jensen, D. Vistisen, T. Fleming, P.P. Nawroth, P. Rossing, M.E. Jørgensen, T. Lauritzen, A. Sandbæk and D.R. Witte |
| 264 | 1 | |c [2016] | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 06.05.2020 | ||
| 520 | |a Aims The glycolysis-derived metabolite methylglyoxal has been linked to clinical microvascular complications, including diabetic nephropathy. We aimed to further investigate the hypothesis that methylglyoxal is involved in decline in renal function by assessing the associations between measures of renal function during a 6-year follow-up in 1481 people with screen-detected Type 2 diabetes, as part of the Danish arm of the ADDITION-Europe trial (ADDITION-DK). Methods Biobank serum samples collected at ADDITION-DK baseline (2001-2006) and follow-up (2009-2010) were used in the current analysis of methylglyoxal. We assessed cross-sectional baseline and longitudinal associations between methylglyoxal and urinary albumin-to-creatinine ratio (ACR) or estimated GFR (eGFR), and between methylglyoxal and categories of albuminuria or reduced eGFR. Results Baseline methylglyoxal was positively associated with ACR at baseline (12% higher ACR per doubling in methylglyoxal levels), and change in methylglyoxal during 6 years of follow-up was inversely associated with change in eGFR (-1.6 ml/min/1.73 m2 per doubling in methylglyoxal change), in models adjusted for age, sex, HbA1c, systolic blood pressure, anti-hypertensive treatment, LDL-cholesterol, lipid-lowering treatment, C-reactive protein and smoking. Conclusions In a population of people with screen-detected Type 2 diabetes, we observed associations between methylglyoxal and markers of renal function: 6-year change in methylglyoxal was inversely associated with 6-year change in eGFR. Also, methylglyoxal at baseline was positively associated with ACR at baseline. Our study lends further support to a role for methylglyoxal in the pathogenesis of diabetic nephropathy. | ||
| 700 | 1 | |a Vistisen, D. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fleming, Thomas |d 1982- |e VerfasserIn |0 (DE-588)1034445294 |0 (DE-627)745607365 |0 (DE-576)382066804 |4 aut | |
| 700 | 1 | |a Nawroth, Peter Paul |d 1954- |e VerfasserIn |0 (DE-588)1020504897 |0 (DE-627)69123941X |0 (DE-576)360517692 |4 aut | |
| 700 | 1 | |a Rossing, P. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Jørgensen, M. E. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lauritzen, T. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sandbæk, A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Witte, D. R. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Diabetic medicine |d Oxford [u.a.] : Wiley-Blackwell, 1984 |g 33(2016), 12, Seite 1625-1631 |h Online-Ressource |w (DE-627)320596699 |w (DE-600)2019647-7 |w (DE-576)091143268 |x 1464-5491 |7 nnas |a Methylglyoxal is associated with changes in kidney function among individuals with screen-detected Type 2 diabetes mellitus |
| 773 | 1 | 8 | |g volume:33 |g year:2016 |g number:12 |g pages:1625-1631 |g extent:7 |a Methylglyoxal is associated with changes in kidney function among individuals with screen-detected Type 2 diabetes mellitus |
| 856 | 4 | 0 | |u https://doi.org/10.1111/dme.13201 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1111/dme.13201 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200506 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 1020504897 |a Nawroth, Peter Paul |m 1020504897:Nawroth, Peter Paul |d 910000 |d 910100 |e 910000PN1020504897 |e 910100PN1020504897 |k 0/910000/ |k 1/910000/910100/ |p 4 | ||
| 998 | |g 1034445294 |a Fleming, Thomas |m 1034445294:Fleming, Thomas |d 910000 |d 910100 |e 910000PF1034445294 |e 910100PF1034445294 |k 0/910000/ |k 1/910000/910100/ |p 3 | ||
| 999 | |a KXP-PPN1697276180 |e 3660652113 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"display":"Jensen, Troels Mygind","family":"Jensen","given":"Troels Mygind","role":"aut"},{"given":"D.","role":"aut","display":"Vistisen, D.","family":"Vistisen"},{"role":"aut","given":"Thomas","family":"Fleming","display":"Fleming, Thomas"},{"given":"Peter Paul","role":"aut","display":"Nawroth, Peter Paul","family":"Nawroth"},{"family":"Rossing","display":"Rossing, P.","given":"P.","role":"aut"},{"display":"Jørgensen, M. E.","family":"Jørgensen","given":"M. E.","role":"aut"},{"role":"aut","given":"T.","display":"Lauritzen, T.","family":"Lauritzen"},{"given":"A.","role":"aut","display":"Sandbæk, A.","family":"Sandbæk"},{"role":"aut","given":"D. R.","family":"Witte","display":"Witte, D. R."}],"title":[{"title":"Methylglyoxal is associated with changes in kidney function among individuals with screen-detected Type 2 diabetes mellitus","title_sort":"Methylglyoxal is associated with changes in kidney function among individuals with screen-detected Type 2 diabetes mellitus"}],"note":["Gesehen am 06.05.2020"],"origin":[{"dateIssuedDisp":"[2016]","dateIssuedKey":"2016"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"physDesc":[{"extent":"7 S."}],"name":{"displayForm":["T.M. Jensen, D. Vistisen, T. Fleming, P.P. Nawroth, P. Rossing, M.E. Jørgensen, T. Lauritzen, A. Sandbæk and D.R. Witte"]},"recId":"1697276180","id":{"doi":["10.1111/dme.13201"],"eki":["1697276180"]},"relHost":[{"part":{"volume":"33","extent":"7","pages":"1625-1631","text":"33(2016), 12, Seite 1625-1631","year":"2016","issue":"12"},"note":["Gesehen am 30.09.09"],"origin":[{"dateIssuedDisp":"1984-","publisherPlace":"Oxford [u.a.] ; Oxford [u.a.] ; Oxford","dateIssuedKey":"1984","publisher":"Wiley-Blackwell ; Blackwell ; Blackwell Science"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"title":"Diabetic medicine","title_sort":"Diabetic medicine","subtitle":"journal of Diabetes UK"}],"language":["eng"],"disp":"Methylglyoxal is associated with changes in kidney function among individuals with screen-detected Type 2 diabetes mellitusDiabetic medicine","id":{"doi":["10.1111/(ISSN)1464-5491"],"issn":["1464-5491"],"eki":["320596699"],"zdb":["2019647-7"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"320596699","pubHistory":["1.1984 -"]}]} | ||
| SRT | |a JENSENTROEMETHYLGLYO2016 | ||